We collected clinical data from the Beijing Chest Hospital and aimed to analyse prognostic factors for advanced NSCLC in patients with different EGFR status and identify the role of EGFR-TKIs in improving OS for patients with EGFR mutations. Here, EGFR is linked to non-small cell lung carcinoma.